Bullish option flow detected in BridgeBio (BBIO) Pharma with 4,472 calls trading, 2.0x expected, and implied vol increasing over 2 points to 47.13%. May-25 30 calls and May-25 40 calls are the most active options, with total volume in those strikes near 2,700 contracts. The Put/Call Ratio is 0.09. Earnings are expected on July 31st.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- Biotech Alert: Searches spiking for these stocks today
- BridgeBio Pharma’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
- BridgeBio Pharma Stock (BBIO) Jumps on Strong Drug Launch
- BridgeBio Pharma’s Earnings Call Highlights Success and Growth
- BridgeBio price target raised to $55 from $52 at Scotiabank